Idiopathic membranoproliferative glomerulonephritis: does it exist?

被引:42
|
作者
Fervenza, Fernando C. [2 ]
Sethi, Sanjeev [1 ,2 ]
Glassock, Richard J. [1 ,3 ]
机构
[1] Mayo Clin, Dept Lab Med & Pathol, Div Anat Pathol, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Internal Med, Div Nephrol & Hypertens, Rochester, MN USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
关键词
complement abnormalities; dense deposit disease; glomerular diseases; glomerulonephritis; C3; membranoproliferative; DENSE DEPOSIT DISEASE; HEMOLYTIC-UREMIC SYNDROME; MONOCLONAL IGG DEPOSITS; ISOLATED C3 DEPOSITS; PROLIFERATIVE GLOMERULONEPHRITIS; GLOMERULAR-DISEASES; CHANGING INCIDENCE; PROTEIN; COMPLEMENT; CLASSIFICATION;
D O I
10.1093/ndt/gfs288
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
When membranoproliferative glomerulonephritis (MPGN) was first delineated as a discrete clinico-pathological entity more than a half-century ago, most cases were regarded as idiopathic (or primary) in nature. Advances in analysis of pathogenetic mechanisms and etiologies underlying the lesion of MPGN have radically altered the prevalence of the truly idiopathic form of MPGN. In addition, MPGN as a category among renal biopsies showing glomerulonephritis has diminished over time. In the modern era, MPGN is mainly classified morphologically on the basis of immunoglobulin (Ig; monoclonal or polyclonal) and complement (C3 only or combined with Ig) deposition and secondarily on the basis of its appearance on ultra-structural examination. Idiopathic MPGN is a diagnosis of exclusion, at least in many adults and a portion of children, and a systematic approach to evaluation will often uncover a secondary cause, such as an infection, autoimmune disease, monoclonal gammopathy, neoplasia, complement dysregulation or a chronic thrombotic microangiopathy. Idiopathic MPGN remains an oendangered species' after its separation from these known causes.
引用
收藏
页码:4288 / 4294
页数:7
相关论文
共 50 条
  • [31] State of the art: C3 glomerulopathy and membranoproliferative glomerulonephritis. A consensus
    Hohenstein, B.
    Licht, C.
    Wiesener, M.
    Amann, K.
    Schaefer, F.
    Serka, C.
    Bergmann, C.
    Kirschfink, M.
    Zipfel, P.
    Hugo, C.
    NEPHROLOGE, 2015, 10 (04): : 327 - 340
  • [32] Membranoproliferative glomerulonephritis and C3 glomerulonephritis: Frequency, clinical features, and outcome in children
    Okuda, Yusuke
    Ishikura, Kenji
    Hamada, Riku
    Harada, Ryoko
    Sakai, Tomoyuki
    Hamasaki, Yuko
    Hataya, Hiroshi
    Fukuzawa, Ryuji
    Ogata, Kentaro
    Honda, Masataka
    NEPHROLOGY, 2015, 20 (04) : 286 - 292
  • [33] Membranoproliferative Glomerulonephritis With Changing Immunofluorescence Pattern
    Satoskar, Anjali A.
    Ibrahim, Dalia Y.
    Brodsky, Sergey, V
    Ayoub, Isabelle
    Nadasdy, Tibor
    Rovin, Brad H.
    KIDNEY INTERNATIONAL REPORTS, 2022, 7 (07): : 1123 - 1127
  • [34] Membranoproliferative glomerulonephritis: the times they are a-changin’
    Jan Willem Cohen Tervaert
    Clinical and Experimental Nephrology, 2014, 18 : 1 - 3
  • [35] Thrombotic microangiopathy mimicking membranoproliferative glomerulonephritis
    Brackman, Damien
    Sartz, Lisa
    Leh, Sabine
    Kristoffersson, Ann-Charlotte
    Bjerre, Anna
    Tati, Ramesh
    Fremeaux-Bacchi, Veronique
    Karpman, Diana
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (10) : 3399 - 3403
  • [36] Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathy
    Noris, Marina
    Donadelli, Roberta
    Remuzzi, Giuseppe
    PEDIATRIC NEPHROLOGY, 2019, 34 (08) : 1311 - 1323
  • [37] Characteristics of membranoproliferative glomerulonephritis based on a new classification at a single center
    Nakano, Marie
    Karasawa, Kazunori
    Moriyama, Takahito
    Uchida, Keiko
    Nitta, Kosaku
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2019, 23 (06) : 852 - 858
  • [38] Rituximab for Treatment of Membranoproliferative Glomerulonephritis and C3 Glomerulopathies
    Rudnicki, Michael
    BIOMED RESEARCH INTERNATIONAL, 2017, 2017
  • [39] Challenges in the Diagnosis and Management of Immune Complex-Mediated Membranoproliferative Glomerulonephritis and Complement 3 Glomerulopathy
    Bomback, Andrew S.
    Charu, Vivek
    Fakhouri, Fadi
    KIDNEY INTERNATIONAL REPORTS, 2025, 10 (01): : 17 - 28
  • [40] Autoimmune forms of thrombotic micorangiopathy and membranoproliferative glomerulonephritis: Indications for a disease spectrum and common pathogenic principles
    Skerka, Christine
    Licht, Christoph
    Mengel, Michael
    Uzonyi, Barbara
    Strobel, Stefanie
    Zipfel, Peter F.
    Jozsi, Mihaly
    MOLECULAR IMMUNOLOGY, 2009, 46 (14) : 2801 - 2807